ストックスクリーナーアプリを入手
9.10
7.44%
0.63
アフターアワーズ：
9.28
0.18
+1.98%
Bioventus Inc (BVS) 最新ニュース
BVS Targets Revenue Range of $600M-$610M for FY26 - GuruFocus
Bioventus Q4 Earnings Call Highlights - MarketBeat
Bioventus Inc (BVS) Q4 2025 Earnings Call Highlights: Strong Org - GuruFocus
Bioventus (NYSE:BVS) Shares Gap UpHere's Why - MarketBeat
Bioventus Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Bioventus (NASDAQ:BVS) Shares Gap Up After Analyst Upgrade - MarketBeat
Bioventus (BVS) Q4 2025 Earnings Call Transcript - AOL.com
Earnings call transcript: Bioventus Inc. Q4 2025 beats EPS estimates, stock surges By Investing.com - Investing.com South Africa
Earnings call transcript: Bioventus Inc. Q4 2025 beats EPS estimates, stock surges - Investing.com India
Bioventus (NASDAQ:BVS) Rating Increased to Strong-Buy at Cantor Fitzgerald - MarketBeat
Bioventus shares jump 7.6% on fourth-quarter earnings beat By Investing.com - Investing.com South Africa
Bioventus: Q4 Earnings Snapshot - KVUE
Bioventus 10-K: $568.1M Revenue, $0.33 Diluted EPS - TradingView
Bioventus (BVS) Exceeds Q4 Revenue Expectations, Eyes Future Gro - GuruFocus
Bioventus Q4 and Full Year 2025 Financial Results - TradingView
BIOVENTUS ($BVS) Releases Q4 2025 Earnings - Quiver Quantitative
Bioventus beats Q4 estimates, guides 2026 revenue in line By Investing.com - Investing.com India
Bioventus (NYSE:BVS) Updates FY 2026 Earnings Guidance - MarketBeat
Bioventus beats Q4 estimates, guides 2026 revenue in line - Investing.com
Bioventus Announces Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
Bioventus Q4 Earnings Assessment - Benzinga
Bioventus beats Q4 revenue estimates on strong demand for pain treatments and surgical solutions - TradingView
Bioventus Earnings Report: Q4 Overview - Benzinga
BVS SEC FilingsBioventus Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Technical Analysis: Will Bioventus Inc benefit from rising consumer demandProduct Launch & Daily Oversold Bounce Ideas - baoquankhu1.vn
Preview: Bioventus's Earnings - Benzinga
Bioventus Inc. $BVS Shares Bought by Royce & Associates LP - MarketBeat
Bioventus (BVS) versus Its Peers Critical Comparison - Defense World
Bioventus (NYSE:BVS) Stock Price Down 0.1%Should You Sell? - MarketBeat
Bioventus Inc. (BVS) Stock Analysis: Unpacking A 63.66% Potential Upside - DirectorsTalk Interviews
Reviewing Bioventus (BVS) and Its Peers - Defense World
Iovance Surged 44% This Week and Its Philadelphia Factory Explains Why - AOL.com
BVS | Bioventus Inc. Class A FinancialsIncome Statement - Quiver Quantitative
Bioventus Inc. to Report Fourth Quarter Fiscal Year 2025 Financial Results on March 5, 2026 - Quiver Quantitative
Bioventus to Report Fourth Quarter of Fiscal Year 2025 Financial Results on March 5, 2026 - GlobeNewswire
BVS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Bioventus (BVS) versus The Competition Head to Head Comparison - Defense World
Can Bioventus Inc. generate free cash flow2025 Technical Patterns & Risk Adjusted Buy/Sell Alerts - mfd.ru
Bioventus Inc. (BVS) Investor Outlook: A 69% Potential Upside And Strong Analyst Ratings - DirectorsTalk Interviews
What is Bioventus Inc.’s valuation compared to sector2025 Bull vs Bear & Daily Growth Stock Tips - mfd.ru
Critical Analysis: Bioventus (BVS) versus The Competition - Defense World
Comparing Bioventus (BVS) & Its Peers - Defense World
Bioventus (BVS) vs. Its Rivals Head to Head Review - Defense World
Bioventus (BVS) SVP gets 4,375 shares, withholds 2,133 for tax - Stock Titan
Reviewing Bioventus (BVS) and The Competition - Defense World
Understanding Momentum Shifts in (BVS) - Stock Traders Daily
Bioventus (BVS) vs. Its Rivals Head to Head Survey - Defense World
Bioventus (BVS) & Its Peers Head-To-Head Survey - Defense World
Barrington Research Initiates Coverage of Bioventus (BVS) with Outperform Recommendation - Nasdaq
Bioventus (BVS) vs. Its Rivals Financial Analysis - Defense World
Risks Report: Is Bioventus Inc. a top pick in the sectorEntry Point & Daily Risk Controlled Trade Plans - mfd.ru
Will Bioventus Inc. stock outperform Nasdaq indexNew Guidance & Fast Exit Strategy with Risk Control - mfd.ru
Will Bioventus Inc. stock maintain growth storyTrade Analysis Summary & High Yield Stock Recommendations - mfd.ru
Volatility Watch: Is Bioventus Inc. a top pick in the sectorOptions Play & Weekly Setup with ROI Potential - mfd.ru
Bioventus Inc. (BVS): Investor Outlook on a Potential 79% Upside in the Medical Devices Sector - DirectorsTalk Interviews
Head-To-Head Review: Bioventus (BVS) vs. Its Rivals - Defense World
Nantahala discloses 9.03% Bioventus (BVS) stake in Schedule 13G/A - Stock Titan
Chipmakers Recap: Is Bioventus Inc attractive for institutional investors2025 Valuation Update & Weekly High Return Stock Forecasts - baoquankhu1.vn
Recap Report: Is Bioventus Inc currently under institutional pressure2025 Major Catalysts & Technical Buy Zone Confirmations - baoquankhu1.vn
Bioventus (NASDAQ:BVS) Upgraded at Barrington Research - MarketBeat
Those who invested in Bioventus (NASDAQ:BVS) three years ago are up 413% - Yahoo Finance
Bioventus (NASDAQ:BVS) Shares Gap UpHere's What Happened - MarketBeat
Barrington Initiates Bioventus at Outperform With $13 Price Target - marketscreener.com
Bioventus (NYSE:BVS) Earns Outperform Rating from Analysts at Barrington Research - MarketBeat
This Nokia Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
2.40%
大文字化:
|
ボリューム (24 時間):